MedPath

Cibinqo

Brand Name: Cibinqo

Generic Name: Abrocitinib

Active
Registration Number

DR-XY48137

Dosage Form

Film-coated Tablet

Issuance Date

June 27, 2022

Expiry Date

June 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
PackagingPVC/PVDC/Aluminum foil blister pack x 7's (Box of 14's and box of 14's - physician's sample)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

AbrocitinibActive
Monograph: Abrocitinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform